Top Markets
#1 Derive Derive +32.97%
#2 Cross Cross +17.26%
#3 Geodnet Geodnet +10.90%
#4 Gama Token Gama Token +9.20%
#5 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.33%
#6 The Bitcoin Bull The Bitcoin Bull +6.93%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +6.82%
#8 Cap Cap +6.44%
#9 OVERTAKE OVERTAKE +6.30%
#10 Starpower Starpower +6.26%
Coin of the day
Derive Derive
설정
언어
한국어
통화
USD
테마
Elixxer Ltd. Elixxer Ltd.

Elixxer Ltd.

ELIXF
주식 순위 #35991
Elixxer Ltd. operates as an investment company specifically focused on the... Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector. Its investment reach extends across Canada, Australia, Italy, Jamaica, and Switzerland. Founded in 2004, the Montreal, Canada-based company adopted its current name, Elixxer Ltd., in August 2019, having previously been known as LGC Capital Ltd.
주가
$0.0335
마지막 동기화: 2026-08-13
시가총액
$3.19M
변동 (1일)
0.00%
변동 (1년)
2,476.92%
국가
CA
거래 Elixxer Ltd. (ELIXF)

카테고리

Healthcare
Elixxer Ltd. (ELIXF)의 배당 이력
Elixxer Ltd. (주식 심볼: ELIXF)은 총 0회의 배당금을 지급했습니다.
모든 배당금의 합계 (주식 분할 반영): 0.00
배당 수익률 (TTM): 0
Elixxer Ltd. (ELIXF)의 2026부터 2026까지 배당 지급 내역
연간 배당 지급
연도 배당금 (주식 분할 조정됨) 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
모든 배당 지급 목록
연도 배당금 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 지급
회사 배당 지급 횟수 국가
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
0.00%
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
0.00%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
0.00%
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
0.00%
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
38.00%
IN